Metzger Michael A sold SNDX
June 1, 2026 · Form 4 insider transaction
Metzger Michael A sold 6,847 shares of Syndax Pharmaceuticals, Inc. at $18.99 per share, a transaction worth $130.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
6,847
Price
$18.99
Total value
$130.0K
InsiderMetzger Michael A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 1, 2026
Filing dateJune 2, 2026
Shares owned after484,843
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.